SARAH EAST-BRUMANA: Open Payments
NPI 1912235201 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 25 payments from 6 companies in 2025. Trend: 2023 $1,038 · 2024 $683 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Boston Scientific Corporation | 2 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: QULIPTA, Kerendia, Axonics, GVOKE HYPOPEN, XIFAXAN, FANAPT, UBRELVY, BOTOX.
Industry payments across NM — which companies pay providers there.
